Clinical trial
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
NCT00040378 · Frederick Schmitt, Other · Completed
Key facts
| NCT number | NCT00040378 |
|---|---|
| Title | Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) |
| Official title | Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) |
| Lead sponsor | Frederick Schmitt, Other |
| Collaborators | National Institute on Aging (NIA) NIH National Cancer Institute (NCI) |
| Status | Completed |
| Study type | Observational |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | alphatocopherol, Selenium, Placebo replacement for vitamin E, Placebo replacement for Selenium |
| Enrollment | 4,246 |
| Start date | May 1, 2002 |
| Primary completion | Jan 1, 2014 |
| Completion | Aug 1, 2016 |
| First posted | Jun 27, 2002 |
| Last update posted | Mar 14, 2018 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: